JBIO
#2463
Jade Biosciences, Inc. - Common Stock
14.0 0 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.71%
Variación mensual
-22.48%
Variación en los últimos 6 meses
-25.45%
Cambio anual
+39.30%
Cierres anteriores
14.3 9
Open
13.9 7
Mínimo
13.8 4
Máximo
14.1 0
Financials
- Market Capitalization 890.36 M
- Employee 55
- Founded 2024
- CEO N/A
- Website www.jadebiosciences.com
- Headquarter Delaware, United States
- FIGI BBG00WGHZFH4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2440 |  MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 10.68 USD | -1.29% | -7.13% | -14.97% | +11.72% | 908.94 M USD | ||
| 2456 |  GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 10.52 USD | +2.14% | +1.35% | -26.69% | -6.90% | 897.50 M USD | ||
| 2497 |  CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 10.05 USD | -4.47% | -6.51% | -22.21% | +45.65% | 845.42 M USD | ||
| 2514 |  ABUS Arbutus Biopharma Corporation - Common Stock | 4.15 USD | -1.66% | -11.13% | -18.95% | -2.35% | 821.07 M USD |